Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05552664 · ClinicalTrials.gov registry record · NA
The Genetic Information and Family Testing (GIFT) Study
A NA study of Cancer, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 3,002
- Enrollment target
- 4
- Study locations
NCT05552664: Completed NA study of Cancer, sponsored by University of Michigan Rogel Cancer Center.
NCT05552664 is a NA study of Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 3,002 participants, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05552664, a NA study of Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,002 participants
- Enrollment target
- 4
- Study locations
Study Summary
The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) and prepare them to subsequently engage their clinicians in informed decision-making about cancer prevention and early detection.
Primary Outcome
The proportion of each enrolled patient's 1st and 2nd degree relatives who receive Color genetic testing through the GIFT platform. For each enrolled patient, this will be calculated as the number of enrolled relatives who obtain a genetic test result from Color (complete the genetic testing process) via the GIFT Study divided by the number of relatives reported on the baseline PICS survey. The endpoint of interest is the presence (as opposed to the absence) of a test result (e.g., positive, un
Conditions Studied
Interventions
- GENETIC GIFT
Study Locations (4)
California
- University of Southern California - Los Angeles
- Stanford University - Stanford
Georgia
- Emory University - Atlanta
Michigan
- University of Michigan Rogel Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,002 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2025-08-10 |
| Phase | NA |
What the finished NCT05552664 record still lists
NCT05552664 is an interventional study that assigns participants to a tested intervention. Its 3,002 participants enrollment target places it among the larger protocols in the corpus, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which GIFT is the first listed.
NCT05552664 reports a single indexed study location in California, Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT05552664 about?
NCT05552664 is a clinical study titled "The Genetic Information and Family Testing (GIFT) Study". The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) ...
What is the current status of trial NCT05552664?
This trial is currently completed. It is a NA study. The enrollment target is 3,002 participants. The study started on 2022-10-24. Estimated completion is 2025-08-10.
What conditions does trial NCT05552664 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05552664?
The interventions under investigation include: GIFT (GENETIC).
Who is sponsoring clinical trial NCT05552664?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05552664 being conducted?
This trial has 4 study locations across California, Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05552664's enrollment target sits among peer trials
3,002 49th of 615 higher than 567 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI